Clinical trial
HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study)
NCT00106886 · Hamilton Health Sciences Corporation, Other · Unknown status
Key facts
| NCT number | NCT00106886 |
|---|---|
| Title | HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study) |
| Official title | HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study) |
| Lead sponsor | Hamilton Health Sciences Corporation, Other |
| Collaborators | Canadian Institutes of Health Research (CIHR) Population Health Research Institute |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cardiovascular Disease, Myocardial Infarction, Stroke, Cancer |
| Intervention type | Drug |
| Interventions | Folic acid, vitamin B6 and B12 or placebo |
| Enrollment | 5,000 |
| Start date | Dec 1, 1999 |
| Completion | Oct 1, 2005 |
| First posted | Apr 1, 2005 |
| Last update posted | Sep 20, 2005 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: